Researchers in Temple University College of Public Health have developed an advanced clinical test that they hope practitioners may soon use to assess stroke patients and work toward recovery of diminished speech abilities.
The Temple Assessment of Language and Short-Term Memory in Aphasia (TALSA) is for diagnosing people with aphasia, a language disorder often caused by stroke. It can impair a person’s ability to speak, write, or process incoming language, even though the person’s intellect and stored knowledge of language remain intact. There are around 100,000 new aphasia cases annually in the United States, and an estimated 2.5 million Americans are living with aphasia.
“TALSA is designed to augment assessment batteries that are out there already, but it incorporates the newest ideas about what aphasia is, and it can produce more sensitive results,” says Dr. Nadine Martin, who heads the Aphasia Rehabilitation Research Laboratory in the College of Public Health.
Dr. Martin’s team created a research version of TALSA in 2008. In 2017, Dr. Martin was awarded a five-year, $2.5 million grant from the National Institutes of Health to develop a clinical, digital version of TALSA, a product that speech pathologists could use in their practices to diagnose patients.
Read more at the College of Public Health.Tags: Friday Letter Submission, Publish on August 30